Insulet Corporation

NASDAQ (USD): Insulet Corporation (PODD)

Last Price

271.24

Today's Change

+26.26 (10.71%)

Day's Change

254.44 - 275.52

Trading Volume

797,476

Profile
PODD

Exchange:  NASDAQ Global Select NASDAQ Global Select

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. James R. Hollingshead Ph.D. Dr. James R. Hollingshead Ph.D.

Full Time Employees:  3,000 3,000

IPO Date:  2007-05-15 2007-05-15

CIK:  0001145197 0001145197

ISIN:  US45784P1012 US45784P1012

CUSIP:  45784P101 45784P101

Beta:  1.21 1.21

Last Dividend:  0.00 0.00

Dcf Diff:  338.80 338.80

Dcf:  -65.65 -65.65

Description

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Address

100 Nagog Park,
Acton, MA 01720, US

978 600 7000

http://www.insulet.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment